ClinicalTrials.Veeva

Menu

Tumor Immune Mechanism of Axillary Lymph Node Metastasis in Early Luminal Type A Breast Cancer

P

Peking University

Status

Unknown

Conditions

Lymph Node Metastases
Luminal A
Immune Microenvironment

Treatments

Other: no intervention

Study type

Observational

Funder types

Other

Identifiers

NCT04322331
IO Panel

Details and patient eligibility

About

Luminal type A breast cancer is a type with good clinical prognosis, and the proportion of lymph node metastasis is low, but a small number of patients have more lymph node metastasis when the primary tumor is very small, and the survival is poor, suggesting that this part of Luminal A breast cancer has the different expression of some genes from that of general Luminal A breast cancer, which affects tumor invasion and participates in the occurrence of tumor metastasis. But the mechanism is not clear, especially in the current tumor microenvironment and immune related mechanisms.We want to investigated the relationship of the transcriptional tumor immune microenvironment with early lymph node metastasis among Luminal A type breast cancer.

Enrollment

120 patients

Sex

Female

Volunteers

No Healthy Volunteers

Inclusion criteria

  • invasive breast cancer with Luminal A type;T1 with positive lymph node or T2/T3 with negative lymph node

Exclusion criteria

  • Missing specimen

Trial design

120 participants in 2 patient groups

T1N+
Description:
T1 tumor with positive lymph node,N1/N2/N3
Treatment:
Other: no intervention
T2/T3N0
Description:
T2/T3 tumor with negative lymph node
Treatment:
Other: no intervention

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems